RPRX position history
The shares of Royalty Pharma (RPRX) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q4: 137,941 shares, $5.5M, 0.81% of portfolio, New
- 2022 Q1: 132,070 shares, $5.1M, 0.83% of portfolio, Reduce −4.3%
- 2022 Q2: 139,012 shares, $5.8M, 1.1% of portfolio, Add +5.3%
- 2022 Q3: 139,024 shares, $5.6M, 1.1% of portfolio, Add 0.0%
- 2022 Q4: 137,371 shares, $5.4M, 0.98% of portfolio, Reduce −1.2%
- 2023 Q1: 137,172 shares, $4.9M, 0.89% of portfolio, Reduce −0.1%
- 2023 Q2: 413,815 shares, $13M, 2.2% of portfolio, Add +201.7%
- 2023 Q3: 412,633 shares, $11M, 2.0% of portfolio, Reduce −0.3%
- 2023 Q4: 505,740 shares, $14M, 2.3% of portfolio, Add +22.6%
- 2024 Q1: 677,437 shares, $41M, 6.1% of portfolio, Add +33.9%
- 2024 Q2: 693,558 shares, $18M, 2.7% of portfolio, Add +2.4%
- 2024 Q3: 857,919 shares, $24M, 3.4% of portfolio, Add +23.7%
- 2024 Q4: 684,007 shares, $17M, 2.5% of portfolio, Reduce −20.3%
- 2025 Q1: 862,018 shares, $27M, 4.0% of portfolio, Add +26.0%
- 2025 Q2: 688,776 shares, $25M, 3.6% of portfolio, Reduce −20.1%
- 2025 Q3: 702,883 shares, $25M, 3.4% of portfolio, Add +2.0%
- 2025 Q4: 744,355 shares, $29M, 4.1% of portfolio, Add +5.9%
- 2026 Q1: 645,425 shares, $31M, 4.5% of portfolio, Reduce −13.3%
- 2026 Q2: 602,028 shares, $34M, 4.6% of portfolio, Reduce −6.7%
- 2026 Q3: 564,461 shares, $33M, 4.3% of portfolio, Reduce −6.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|